[36] [75] [77] Narcolepsy Narcolepsy is a chronic sleep-wake disorder that is associated with excessive daytime sleepiness, cataplexy, and sleep paralysis
It can be taken intravenously, orally (swallowed by mouth), or by inhalation by use of a nebulizer
The body handles ordinary demands, a stressful week, a drink with dinner, a seasonal illness, without falling significantly behind
Maintain adequate nutrition: Ensure sufficient carbohydrate, protein, and overall caloric intake to support research protocol Assess joint and neurological symptoms: Monitor for swelling, carpal tunnel symptoms, or other adverse effects regularly Periodic biomarker assessment: Re-check glucose, lipids, and metabolic markers at mid-point and end of protocol Plan discontinuation protocol: Gradually reduce dosing over 1-2 weeks at research conclusion rather than abrupt cessation Post-research assessment: Verify that all parameters (glucose, lipids, metrics, symptoms) return to baseline after discontinuation Conclusion IGF-1 LR3 has a generally favourable safety profile when used in research with appropriate doses, duration, and monitoring protocols
This distinction is essential for accurate dosing
